FEDERAL HEALTH POLICY STRATEGIES for UPMC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| COLIN ROSKEY | — |
| THOMAS SCULLY | — |
Health Issues HCR
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| COLIN ROSKEY | — |
| THOMAS SCULLY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.